Clinical Trial Update: Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing adding vildagliptin versus glimepiride to metformin in type 2 diabetes patients with coronary artery disease, focusing on inflammation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• Vildagliptin (vildagliptin)
• metformin (metformin)

Snippet

Sponsor: Damanhour University | Conditions: Coronary Artery Disease, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED